Steven Josefowicz

The latest summary of “How Long Covid Exhausts the Body” by @joshkellerjosh. Visual journalism at its best 👀 Happy to contribute insights with @nathavindra. Ft. @PutrinoLab @michelle_monje @microbeminded2 @Survivor_Corps @itsbodypolitic & patients. nytimes.com/interactive/20…

LIVE at Cold Spring Harbor Labs in Nov. 2022. Executive Producers: Art Weiss, Sasha Rudensky, Ellen Rothenberg and Jon Kagan are pleased to present the conference: "Gene Expression and Signaling in the Immune System" Stars and supporting cast to follow. meetings.cshl.edu/meetings.aspx?…

Here is the #preprint alert and summary thread: twitter.com/JosefowiczLab/…

Yes!- An illuminating overview of long COVID in the context of other "long" medical conditions from @Doclief. Great questions @melina_manolas - stay tuned for preprint link and twitter thread from @JosefowiczLab

Happy New Year from the Josefowicz Lab! To end 2019, check out our latest News and Views in @NatImmunol! nature.com/articles/s4159… @Alexia_MdP @sjosefowicz

I missed the haikus! Thanks for coming back!

Two #bioRxiv preprints on the role of DOT1L in the immune system! Paper 1- Loss of DOT1L in CD4+ T cells increases IFNg/Th1 responses, revealing a role of DOT1L in T cell plasticity / differentiation. @MonashBDI @colbyzaph @KimLJacobson @SebScheer biorxiv.org/content/10.110…

Latest from @BogunovicLab. Incredible, 18y journey of a brave girl to cure. Heterozygous, mosaic, gain-of-function mutation in JAK1, with differing genotype to “transciptotype” on a single cell level. #autoinflammatory #RareDisease biorxiv.org/content/10.110…

Nice aggregation of data. I think some additional analyses are required, especially regression modeling and correction of outcome variables (comments submitted on BioRxiv). Useful! Insights from a survey-based analysis of the academic job market biorxiv.org/content/10.110…

PRC2 bridges non-adjacent nucleosomes to establish heterochromatin biorxiv.org/cgi/content/sh… #bioRxiv